Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor

被引:44
|
作者
Bosch, MP [1 ]
Campos, F
Niubó, I
Rosell, G
Díaz, JL
Brea, J
Loza, MI
Guerrero, A
机构
[1] CSIC, IIQAB, Dept Biol Organ Chem, ES-08034 Barcelona, Spain
[2] Univ Barcelona, Dept Pharmacol & Med Sci, CSIC, Fac Pharm, E-08028 Barcelona, Spain
[3] Lab Almirall Prodesfarma, Barcelona 08024, Spain
[4] Univ Santiago de Compostela, Fac Pharm, Dept Pharmacol, Santiago De Compostela 1578, Spain
关键词
D O I
10.1021/jm031143+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New adenosine derivatives have been synthesized and tested as putative agonists of adenosine receptors. Compounds 2-6 derive from the introduction of several types of substituents (electron donating, electron withdrawing, and halogens) in the para-position of the phenyl ring of the parent compound 1, and compound 7 lacks the hydroxyl group of amino alcohol 1. In radioligand binding assays using recombinant human A(1), A(2A), A(2B), and A(3) receptors, all compounds showed very low or negligible affinity for A(1) and A(2B) receptors but compounds 3, 5, and 7 displayed a remarkably potent affinity for the A2A receptor with K-i values of 1-5 nM. Bromo derivative 3 displayed a selectivity A(1)/A(2A) = 62 and A(3)/A(2A) = 16 whereas the presence of a hydroxyl group (compound 5) improved the selectivity of A(1)/A(2A) and A(3)/A(2A) to 120- and 28-fold, respectively. When the methoxy derivative 4 lacks the hydroxyl group on the side chain (compound 7), the binding affinity for A(2A) is increased to 1 nM, improving selectivity ratios to 356- and 100-fold against A(1) and A(3), respectively. In Chinese hamster ovary cells transfected with human A2A and A(2B) receptors, most compounds showed a remarkable activity for the A2A receptor, except chloro derivative 2, with EC50 values ranging from 1.4 to 8.8 nM. The compounds behaved as good A(2A) agonists, and all were more selective than 5'-(N-ethylearboxamino)adenosine (NECA), with A(2B)/A(2A) ratios of cAMP accumulation ranging from 48 for compound 2 to 666 for compound 7 while the corresponding A(2B)/A(2A) ratio for NECA was only 9. Compounds 1, 3, 5, and 7 also displayed higher selectivities than NECA up to 100-fold in isolated aortas of rat and guinea pig. In guinea pig tracheal rings precontracted by carbachol, compounds 2 and 4 were more potent than adenosine (100-fold) and NECA (10-fold), whereas compounds 1 and 7 displayed similar effects to NECA. Pretreatment of the tracheal rings with A(2), A(2A), and A(2B) receptor antagonists 3,7-dimethyl-L-propargylxanthine, 8-(3-chlorostyryl)caffeine, and alloxazine produced a marked inhibition of the tracheal relaxations induced by compounds 1, 2, and 4, but none of the compounds showed selectivity toward any of the adenosine receptors.
引用
收藏
页码:4041 / 4053
页数:13
相关论文
共 50 条
  • [31] Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging
    van Waarde, Aren
    Dierckx, Rudi A. J. O.
    Zhou, Xiaoyun
    Khanapur, Shivashankar
    Tsukada, Hideo
    Ishiwata, Kiichi
    Luurtsema, Gert
    de Vries, Erik F. J.
    Elsinga, Philip H.
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (01) : 5 - 56
  • [32] A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists
    Jacobson, KA
    Ohno, M
    Duong, HT
    Kim, SK
    Tchilibon, S
    Cesnek, M
    Holy, A
    Gao, ZG
    CHEMISTRY & BIOLOGY, 2005, 12 (02): : 237 - 247
  • [33] A covalent antagonist for the human adenosine A2A receptor
    Yang, Xue
    Dong, Guo
    Michiels, Thomas J. M.
    Lenselink, Eelke B.
    Heitman, Laura
    Louvel, Julien
    IJzerman, Ad P.
    PURINERGIC SIGNALLING, 2017, 13 (02) : 191 - 201
  • [34] A covalent antagonist for the human adenosine A2A receptor
    Xue Yang
    Guo Dong
    Thomas J.M. Michiels
    Eelke B. Lenselink
    Laura Heitman
    Julien Louvel
    Ad P. IJzerman
    Purinergic Signalling, 2017, 13 : 191 - 201
  • [35] Molecular Modeling of the Human A2a Adenosine Receptor
    A. A. Ivanov
    I. I. Baskin
    V. A. Palyulin
    N. S. Zefirov
    Doklady Biochemistry and Biophysics, 2003, 389 (1-6) : 94 - 97
  • [36] The Crystallographic Model of a Human A2A Adenosine Receptor
    Jaakola, Veli-Pekka
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2010, 66 : S13 - S13
  • [37] Vasodilator stress imaging using new adenosine A2A receptor agonists administered by bolus injection
    Glover, DK
    Ruiz, M
    Takehana, K
    Petruzella, FD
    Watson, DD
    Beller, GA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 492A - 492A
  • [38] The anti-inflammatory and cardioprotective properties of A2A adenosine receptor agonists
    Glover, David
    Patel, Rajan
    Broisat, Alexis
    Kabul, Hasan
    Ruiz, Mirta
    Goodman, Craig
    Kramer, Christopher
    Linden, Joel
    Beller, George
    PURINERGIC SIGNALLING, 2008, 4 : S95 - S95
  • [39] Adenosine A2A agonists as therapy for glomerulonephritis
    Ferenbach, David A.
    Hughes, Jeremy
    KIDNEY INTERNATIONAL, 2011, 80 (04) : 329 - 331
  • [40] Neural network approaches applied to selective A2a adenosine receptor agonists
    Mager, PP
    MEDICINAL CHEMISTRY RESEARCH, 1998, 8 (06) : 277 - 290